Quidel | QDEL - 现金及等价物



金融业
股票价格
USD
资产
USD 5.72B
现金及等价物
USD 123.4M
销售成本
USD 407M
流动资产
USD 1.38B
流动负债
USD 993.4M
债务
USD 2.87B
EBIT
USD -15.3M
EBITDA
USD 129.3M
员工
6.6K
EPS每股收益
USD -1.27
股本和储备
USD 1.85B
销售毛利
USD 223.9M
债务利息支出
USD 5.63B
利息收入
USD -1.35
贷款资金
USD 2.54B
市值
USD 802.9M
净收入
USD -92.9M
营业费用
USD 646.2M
营业利润
USD -15.3M
普通股股本
USD 68.1M
PE价格收益
2.03
税前利润
USD -79.5M
销售收入
USD 630.9M
销售和管理费用
USD 189.7M
股票
USD 618.9M
贸易债权人
USD 236.5M
应收帐款人
USD 352M


现金及等价物 更改 日
Abbott USD 6.8B 1.72B 2026-03
Agilent USD 1.76B 49M 2026-06
Becton, Dickinson and Co. USD 708M 105M 2026-06
Bruker USD 184.9M 51.5M 2026-06
Cerus USD 19.96M 4.29M 2025-12
Charles River Laboratories USD 192.02M 195K 2026-06
Danaher USD 4.35B 1.35B 2026-06
Haemonetics USD 223.38M 22.06M 2026-06
Illumina USD 1.09B 329M 2026-03
IQVIA Holdings USD 1.91B 38M 2026-06
Merit Medical Systems USD 448.7M 39.38M 2026-06
Mettler Toledo International USD 51.38M 9.19M 2026-06
Myriad Genetics USD 115.2M 9.2M 2026-06
Neogen USD 172M 13.5M 2026-06
OraSure Technologies USD 160.58M 16.38M 2026-06
Pacific Biosciences Of California USD 61M 4.73M 2026-06
Quidel USD 123.4M 17M 2026-06
Revvity USD 1.02B 162.62M 2026-06
STAAR Surgical USD 148.58M 16.72M 2026-06
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Waters USD 539M 77M 2026-06